{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:41:33Z","timestamp":1757781693134},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/s0889-8545(03)00119-0","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T14:53:30Z","timestamp":1113836010000},"page":"1-20","source":"Crossref","is-referenced-by-count":11,"title":["First-trimester screening for aneuploidy"],"prefix":"10.1016","volume":"31","author":[{"given":"Karlla W","family":"Brigatti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fergal D","family":"Malone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0889-8545(03)00119-0_BIB1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/(SICI)1097-0223(199602)16:2<143::AID-PD825>3.0.CO;2-F","article-title":"Prenatal screening for Down's syndrome using inhibin-A as a serum marker","volume":"16","author":"Wald","year":"1996","journal-title":"Prenat Diagn"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/096914139700400402","article-title":"Antenatal screening for Down's syndrome","volume":"4","author":"Wald","year":"1997","journal-title":"J Med Screen"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1067\/mob.2000.104802","article-title":"First trimester screening for aneuploidy: research or standard of care?","volume":"182","author":"Malone","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.318.7176.81","article-title":"Using fetal nuchal translucency to screen for major congenital heart defects at 10\u201314 weeks of gestation: population based cohort study","volume":"318","author":"Hyett","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1469-0705.2001.00454.x","article-title":"Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester","volume":"18","author":"Souka","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/humrep\/14.3.823","article-title":"Lympathic vessel hypoplasia in fetuses with Turner syndrome","volume":"14","author":"Von Kaisenberg","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/(SICI)1097-0223(199609)16:9<797::AID-PD948>3.0.CO;2-M","article-title":"Nuchal translucency cannot be used as a screening test for chromosomal abnormalities in the first trimester of pregnancy in a routine ultrasound practice","volume":"16","author":"Kornman","year":"1996","journal-title":"Prenat Diagn"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB8","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1056\/NEJM199712043372303","article-title":"Increased nuchal translucency as a marker for fetal chromosomal defects","volume":"337","author":"Taipale","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1097-0223(199801)18:1<29::AID-PD213>3.0.CO;2-N","article-title":"Results of routine fetal nuchal translucency measurement at weeks 10\u201313 in 4233 unselected pregnant women","volume":"18","author":"Hafner","year":"1998","journal-title":"Prenat Diagn"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1471-0528.1998.tb09351.x","article-title":"First trimester sonographic detection of chromosomal abnormalities in an unselected population","volume":"105","author":"Economides","year":"1998","journal-title":"BJOG"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/(SICI)1097-0223(199802)18:2<133::AID-PD236>3.0.CO;2-O","article-title":"Evaluation of first-trimester screening by fetal nuchal translucency and maternal age","volume":"18","author":"Theodoropoulos","year":"1998","journal-title":"Prenatal Diagnosis"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0140-6736(97)11280-6","article-title":"UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10\u201314 weeks of gestation","volume":"352","author":"Snijders","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1469-0705.1998.12030163.x","article-title":"Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population","volume":"12","author":"Pajkrt","year":"1998","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/(SICI)1097-0223(199904)19:4<360::AID-PD556>3.0.CO;2-U","article-title":"First-trimester screening for Down syndrome using nuchal translucency measurement with free \u03b2\u2013hCG and PAPP-A between 10 and 13 weeks of pregnancy \u2013 the combined test","volume":"19","author":"De Biasio","year":"1999","journal-title":"Prenat Diagn"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB15","first-page":"183","article-title":"Traslucencia nucal fetal, un marcador de alteraciones cromosomicas en el primer trimester","volume":"45","author":"Quispe","year":"1999","journal-title":"Ginecol Obstet Mex"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB16","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1471-0528.1999.tb08432.x","article-title":"The value of sonography in early pregnancy for the detection of fetal abnormalities in an unselected population","volume":"106","author":"Whitlow","year":"1999","journal-title":"BJOG"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB17","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1471-0528.1999.tb08109.x","article-title":"Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10\u201314 weeks of gestation as part of routine antenatal care in an unselected population","volume":"106","author":"Schwarzler","year":"1999","journal-title":"BJOG"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB18","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1259\/bjr.72.862.10673944","article-title":"First trimester nuchal translucency: effective routine screening for Down's syndrome","volume":"72","author":"Thilaganathan","year":"1999","journal-title":"Br J Radiol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0029-7844(00)00881-4","article-title":"First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency","volume":"96","author":"Krantz","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1479-828X.2000.tb03337.x","article-title":"First trimester ultrasound with nuchal translucency measurement for Down syndrome risk estimation using software developed by the Fetal Medicine Foundation, United Kingdom \u2013 the first 2000 examinations in Newcastle, New South Wales, Australia","volume":"40","author":"O'Callaghan","year":"2000","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/sj.ejhg.5200655","article-title":"Evaluation of first trimester maternal serum and ultrasound screening for Down's syndrome in Eastern and Northern Finland","volume":"9","author":"Niemimaa","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1469-0705.2001.00458.x","article-title":"Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester and serum biochemistry in the second trimester in a low-risk population","volume":"18","author":"Schuchter","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1469-0705.2001.00457.x","article-title":"Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study","volume":"18","author":"Audibert","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB24","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0306-5456(01)00241-8","article-title":"The use of nuchal translucency measurement and second trimester biochemical markers in screening for Down's syndrome","volume":"108","author":"Michailidis","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.0960-7692.2001.00604.x","article-title":"Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland","volume":"18","author":"Gasiorek-Wiens","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.0960-7692.2001.00583.x","article-title":"Fetal nuchal translucency screening in 12,496 pregnancies in Sardinia","volume":"18","author":"Zoppi","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB27","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1046\/j.0960-7692.2001.00588.x","article-title":"First-trimester screening for chromosomal abnormalities by fetal nuchal translucency in a Brazilian population","volume":"18","author":"Brizot","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB28","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1034\/j.1600-0412.2001.801205.x","article-title":"Four years experience of first-trimester nuchal translucency screening for fetal aneuploidies with increasing regional availability","volume":"80","author":"Wayda","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/pd.288","article-title":"The first trimester \u2018combined test\u2019 for the detection of Down syndrome pregnancies in 4939 unselected pregnancies","volume":"22","author":"Schuchter","year":"2002","journal-title":"Prenat Diagn"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1590\/S0100-72032002000300004","article-title":"Medida da translucencia nucal no rastreamento de anomalies cromossomicas","volume":"24","author":"Murta","year":"2002","journal-title":"Rev Bras Ginecol Obstet"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB31","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/humrep\/17.4.1093","article-title":"Down's syndrome screening with nuchal translucency at 12 + 0 \u2013 14 + 0 weeks and maternal serum markers at 14 + 1 \u2013 17 + 0 weeks: a prospective study","volume":"17","author":"Rozenberg","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1471-0528.2002.01394.x","article-title":"Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study","volume":"109","author":"Crossley","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB33","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/pd.382","article-title":"Comparison and integration of first trimester nuchal translucency and second trimester maternal serum screening for fetal Down syndrome","volume":"22","author":"Lam","year":"2002","journal-title":"Prenat Diagn"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1469-0705.2002.00808.x","article-title":"One-stop clinic for assessment of risk for trisomy 21 at 11\u201314 weeks: a prospective study of 15,030 pregnancies","volume":"20","author":"Bindra","year":"2002","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB35","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0029-7844(02)02145-2","article-title":"Measurement of nuchal translucency as a single strategy in trisomy 21 screening: should we use any other marker?","volume":"100","author":"Comas","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1258\/096914103321824133","article-title":"First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)","volume":"10","author":"Wald","year":"2003","journal-title":"J Med Screen"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1469-0705.1995.05030161.x","article-title":"First-trimester ultrasound screening for fetal aneuploidies in women over 35 and under 35 years of age","volume":"5","author":"Szabo","year":"1995","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB38","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1471-0528.1995.tb11290.x","article-title":"First trimester nuchal translucency: problems with screening the general population 2","volume":"102","author":"Bewley","year":"1995","journal-title":"BJOG"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB39","first-page":"257","article-title":"First-trimester Down's syndrome screening by fetal nuchal translucency measurement in Taiwan","volume":"100","author":"Jou","year":"2001","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB40","first-page":"319","article-title":"Combined measurement of fetal nuchal translucency, maternal serum free \u03b2\u2013hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening","volume":"100","author":"Tsai","year":"2001","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB41","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0140-6736(98)22031-9","article-title":"Antenatal screening for Down's syndrome: where are we and where next?","volume":"352","author":"Haddow","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB42","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0029-7844(99)00496-2","article-title":"Effect of study design on the association between nuchal translucency measurement and Down syndrome","volume":"94","author":"Mol","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB43","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(96)91391-4","article-title":"Down's syndrome screening in the UK","volume":"47","author":"Nicolaides","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB44","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0140-6736(05)64047-0","article-title":"Fetal nuchal translucency test for Down's syndrome","volume":"350","author":"Cuckle","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/(SICI)1097-0223(199805)18:5<519::AID-PD398>3.0.CO;2-U","article-title":"Correct estimation of parameters for ultrasound nuchal translucency screening","volume":"18","author":"Nicolaides","year":"1998","journal-title":"Prenat Diagn"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(02)00187-0","article-title":"Advances in prenatal screening for Down syndrome: II first trimester testing, integrated testing, and future directions","volume":"324","author":"Penn","year":"2002","journal-title":"Clin Chim Acta"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1469-0705.1996.07030170.x","article-title":"The prevalence of non-viable pregnancy at 10\u201313 weeks of gestation","volume":"7","author":"Pandya","year":"1996","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/jms.5.1.3","article-title":"Down's syndrome screening in twins","volume":"5","author":"Cuckle","year":"1998","journal-title":"J Med Screen"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB49","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/humrep\/15.9.2008","article-title":"Early prediction of severe twin-to-twin transfusion syndrome","volume":"15","author":"Sebire","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB50","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/(SICI)1097-0223(199805)18:5<511::AID-PD389>3.0.CO;2-#","article-title":"Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome","volume":"18","author":"Wald","year":"1998","journal-title":"Prenat Diagn"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB51","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM199908123410701","article-title":"Integrated screening for Down's syndrome based on tests performed during the first and second trimesters","volume":"341","author":"Wald","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB52","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(01)06724-1","article-title":"Time for a total shift to first-trimester screening for Down's syndrome","volume":"358","author":"Cuckle","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB53","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/pd.132","article-title":"Assessment of the value of reporting partial screening results in prenatal screening for Down syndrome","volume":"21","author":"Hackshaw","year":"2001","journal-title":"Prenat Diagn"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB54","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1046\/j.1469-0705.1998.12060380.x","article-title":"Screening for chromosomal abnormalities at 10\u201314 weeks: the role of ductus venosus blood flow","volume":"12","author":"Matias","year":"1998","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB55","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1469-0705.2001.00387.x","article-title":"Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome","volume":"17","author":"Bilardo","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB56","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000048007","article-title":"First-trimester ductus venosus velocimetry in relation to nuchal translucency thickness and fetal karyotype","volume":"17","author":"Zoppi","year":"2002","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB57","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1469-0705.2001.00395.x","article-title":"The role of ductus venosus blood flow assessment in screening for chromosomal abnormalities at 10\u201316 weeks of gestation","volume":"17","author":"Antolin","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB58","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000063185","article-title":"Application of ductus venosus Doppler velocimetry for the detection of fetal aneuploidy in the first trimester of pregnancy","volume":"17","author":"Murta","year":"2002","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB59","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1471-0528.2002.01482.x","article-title":"Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosus","volume":"109","author":"Mavrides","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB60","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1469-0705.2001.00412.x","article-title":"Assessment of ductus venosus flow during the first and early second trimesters: what can we expect?","volume":"17","author":"Hecher","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB61","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(01)06709-5","article-title":"Absence of nasal bone in fetuses with trisomy 21 at 11\u201314 weeks of gestation: an observational study","volume":"358","author":"Cicero","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB62","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(02)08289-2","article-title":"Absence of nasal bone and detection of trisomy 21","volume":"359","author":"De Biasio","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB63","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM199804023381404","article-title":"Screening of maternal serum for fetal Down's syndrome in the first trimester","volume":"338","author":"Haddow","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB64","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0140-6736(05)64050-0","article-title":"Results of measurement of nuchal translucency ultrasound before and after training","volume":"350","author":"Monni","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB65","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/(SICI)1097-0223(199607)16:7<629::AID-PD922>3.0.CO;2-X","article-title":"Establishment and application of a normal range for nuchal translucency across the first trimester","volume":"16","author":"Scott","year":"1996","journal-title":"Prenat Diagn"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB66","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1469-0705.1997.09040244.x","article-title":"The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome","volume":"9","author":"Kadir","year":"1997","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB67","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/pd.131","article-title":"Inaccurate estimation of risk in second trimester serum screening for Down syndrome among women who have already had first trimester screening","volume":"21","author":"Hackshaw","year":"2001","journal-title":"Prenat Diagn"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB68","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0002-9378(97)70400-9","article-title":"Maternal serum screening for Down syndrome in the United States: a 1995 survey","volume":"176","author":"Palomaki","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB69","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1067\/mob.2002.126980","article-title":"Antenatal Down syndrome screening in the United States in 2001: a survey of maternal-fetal medicine specialists","volume":"187","author":"Egan","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB70","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(97)12346-7","article-title":"Randomized trial to assess safety and fetal outcome of early and midtrimester amniocentesis","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0889-8545(03)00119-0_BIB71","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0029-7844(99)00613-4","article-title":"Cost-benefit analysis of prenatal diagnosis for Down syndrome using the British or the American Approach","volume":"95","author":"Vintzileos","year":"2000","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854503001190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854503001190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T06:59:13Z","timestamp":1548572353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854503001190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0889854503001190"],"URL":"https:\/\/doi.org\/10.1016\/s0889-8545(03)00119-0","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}